Fujitsu conducts project with Takeda and National Cancer Center Japan to analyze and visualize of patient journey with ovarian cancer
These treatment patterns are expected to assist physicians and patients in jointly selecting optimal treatment.
- These treatment patterns are expected to assist physicians and patients in jointly selecting optimal treatment.
- This study was conducted based on a joint research agreement that Fujitsu concluded with Takeda and the National Cancer Center Japan in May 2021 with the aim of identifying clinical challenges that will contribute to improving the quality and therapeutic efficacy of personalized ovarian cancer treatment.
- In the future, the platform will be able to extract patient medical data and convert it into HL7 FHIR(2).
- It includes electronic medical record data, medical accounting data, health checkup data, patient registry data, and data obtained from wearable devices.